Update on high-altitude pulmonary edema: Pathogenesis, prevention, and treatment

Wilderness and Environmental Medicine

Volumn 19, Issue 4, 2008, Pages 293-303

  Stream, Joshua O ^a   Grissom, Colin K ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Altitude illness; HAPE; High altitude; Mountaineering; Pulmonary edema

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; HYDRALAZINE; NIFEDIPINE; NITRIC OXIDE; PHENTOLAMINE; SALMETEROL; TADALAFIL; VASODILATOR AGENT;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; CAPILLARY ENDOTHELIUM; CLINICAL PRACTICE; DYSPEPSIA; HEADACHE; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOXIC LUNG VASOCONSTRICTION; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG CAPILLARY; LUNG CAPILLARY PRESSURE; LUNG EDEMA; LUNG PERFUSION; MOOD DISORDER; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PERIPHERAL EDEMA; PHYSICAL ACTIVITY; REVIEW; SYMPATHETIC TONE; TACHYCARDIA;

EID: 57749181064     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/07-WEME-REV-173.1     Document Type: Review

References (96)

1. Houston CS. Acute pulmonary edema of high altitude. N Engl J Med. 1960;263:478-480.
2. Hultgren HN, Spickard W. Medical experiences in Peru. Stanford Med Bull. 1960;18:76-95.
3. Hackett P, Roach RC. High-altitude medicine. In: Auerbach P, ed. Wilderness Medicine. 5th ed. St. Louis, MO: Mosby; 2007:2-36.
4. Hultgren HN, Honigman B, Theis K, Nicholas D. High-altitude pulmonary edema at a ski resort. West J Med. 1996;164:222-227.
5. Grissom C. High-altitude diseases (HACE/HAPE). In: Fein A, Kamholz S, Ost D, eds. Respiratory Emergencies. London: Hodder Arnold; 2006:253-267.
6. Vock P, Fretz C, Franciolli M, Bartsch P. High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology. 1989;170(3 Pt 1):661-666.
7. Vock P, Brutsche MH, Nanzer A, Bartsch P. Variable radiomorphologic data of high altitude pulmonary edema: features from 60 patients. Chest. 1991;100:1306-1311.
8. Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325:1284-1289.
9. Sophocles A Jr. High-altitude pulmonary edema in Vail, Colorado, 1975-1982. West J Med. 1986;144:569-573.
10. Reeves J, Wagner J, Zafren K, Honigman B, Schoene R. Seasonal variation in barometric pressure and temperature in Summit County: effect on altitude illness. In: Sutton J, Houston C, Coates G, eds. Hypoxia and Molecular Medicine. Burlington, VT: Charles S Houston; 1993:275-281.
11. Durmowicz AG, Noordeweir E, Nicholas R, Reeves JT Inflammatory processes may predispose children to high-altitude pulmonary edema. J Pediatr. 1997;130:838-840.
12. Grissom CK. High altitude illness prevention and treatment. In: Braunwald E, ed. Harrison's Internal Medicine Online. Update 12/8/2006. The McGraw-Hill Companies, AccessMedicine. Available at: http://www.accessmedicine. com. Accessed June 22, 2007.
13. Bärtsch P. High altitude pulmonary edema. Med Sci Sports Exerc. 1999;31(suppl 1):S23-S27.
14. Carpenter TC, Reeves JT, Durmowicz AG. Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema. J Appl Physiol. 1998;84: 1048-1054.
15. Ono S, Westcott JY, Chang SW, Voelkel NF. Endotoxin priming followed by high altitude causes pulmonary edema in rats. J Appl Physiol. 1993;74:1534-1542.
16. Hanaoka M, Kubo K, Yamazaki Y, et al. Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation. 1998;97:1124-1128.
17. Arnett FC. High-altitude pulmonary edema: an immunogenetically mediated disease? Circulation. 1998;97:1111-1113.
18. Naeije R, De Backer D, Vachiery J-L, De Vuyst P. High-altitude pulmonary edema with primary pulmonary hypertension. Chest. 1996;110:286-289.
19. Hackett PH, Creagh CE, Grover RF, et al. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med. 1980;302:1070-1073.
20. Khoury GH, Hawes CR. Atrial septal defect associated with pulmonary hypertension in children living at high altitude. J Pediatr. 1967;70:432-435.
21. Willerson JT, Baggett AE Jr, Thomas JW, Goldblatt A. Ventricular septal defect with altitude-dependent pulmonary hypertension. N Engl J Med. 1971;285:157-158.
22. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA. 2006;296: 2954-2958.
23. Levine BD, Grayburn PA, Voyles WF, Greene ER, Roach RC, Hackett PH. Intracardiac shunting across a patent foramen ovale may exacerbate hypoxemia in high-altitude pulmonary edema. Ann Intern Med. 1991;114:569-570.
24. Cremona G, Asnaghi R, Baderna P, et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet. 2002;359:303-309.
25. Podolsky A, Eldridge MW, Richardson RS, et al. Exercise-induced VA/Q inequality in subjects with prior high-altitude pulmonary edema. J Appl Physiol. 1996;81:922-932.
26. Scoggin CH, Hyers TM, Reeves JT, Grover RF. High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N Engl J Med. 1977;297:1269-1272.
27. Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation. 1971;44:759-770.
28. Kawashima A, Kubo K, Kobayashi T, Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol. 1989;67:1982-1989.
29. Schoene RB, Hackett PH, Henderson WR, et al. High-altitude pulmonary edema: characteristics of lung lavage fluid. JAMA. 1986;256:63-69.
30. Schoene RB, Swenson ER, Pizzo CJ, et al. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J Appl Physiol. 1988;64: 2605-2613.
31. West J, Mathieu-Costello O. High altitude pulmonary edema is caused by stress failure of pulmonary capillaries. Int J Sports Med. 1992;13(suppl 1):S54-S58.
32. West JB, Colice GL, Lee YJ, et al. Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J. 1995;8:523-529.
33. Maggiorini M, Melot C, Pierre S, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 2001;103:2078-2083.
34. Hackett PH, Roach RC, Schoene RB, Harrison GL, Mills WJ Jr. Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol. 1988;64:1268-1272.
35. Matsuzawa Y, Fujimoto K, Kobayashi T, et al. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol. 1989;66:1152-1157.
36. Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bartsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J. 1995;8:1825-1833.
37. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation. 1999;99:1713-1718.
38. Sartori C, Vollenweider L, Loffler BM, et al. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation. 1999;99:2665-2668.
39. Busch T, Bartsch P, Pappert D, et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med. 2001,163:368-373.
40. Duplain H, Sartori C, Lepori M, et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med. 2000;162:221-224.
41. Rintamaki H. Human responses to cold. Alaska Med. 2007;49(suppl 2):29-31.
42. Hackett PH, Roach RC, Hartig GS, Greene ER, Levine BD. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int J Sports Med. 1992;13(suppl 1):S68-S71.
43. Modesti PA, Vanni S, Morabito M, et al. Role of endothelin-1 in exposure to high altitude: acute mountain sickness and endothelin-1 (ACME-1) study. Circulation. 2006; 114:1410-1416.
44. Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA. 2002;287:2228-2235.
45. Berger M, Hesse C, Dehnert C, et al. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am J Respir Crit Care Med. 2005;172:763-767.
46. Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 2002;106:826-830.
47. Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med. 2004; 141:169-177.
48. Richalet JP, Gratadour P, Robach P, et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med. 2005;171:275-281.
49. Grissom CK, Albertine KH, Elstad MR. Alveolar haemorrhage in a case of high altitude pulmonary oedema. Thorax. 2000;55:167-169.
50. West JB. Invited review: pulmonary capillary stress failure. J Appl Physiol. 2000;89:2483-2489; discussion 2497.
51. West JB, Mathieu-Costello O, Jones JH, et al. Stress failure of pulmonary capillaries in racehorses with exercise-induced pulmonary hemorrhage. J Appl Physiol. 1993;75: 1097-1109.
52. Hopkins SR, Schoene RB, Henderson WR, Spragg RG, Martin TR, West JB. Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med. 1997;155:1090-1094.
53. Bartsch P, Waber U, Haeberli A, et al. Enhanced fibrin formation in high-altitude pulmonary edema. J Appl Physiol. 1987;63:752-757.
54. Bachofen H, Schurch S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: barrier lesions. Am Rev Respir Dis. 1993;147:997-1004.
55. Neal CR, Michel CC. Openings in frog microvascular endothelium induced by high intravascular pressures. J Physiol. 1996;492(part 1):39-52.
56. Elliott AR, Fu Z, Tsukimoto K, Prediletto R, Mathieu-Costello O, West JB. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol. 1992;73:1150-1158.
57. Rios B, Driscoll DJ, McNamara DG. High-altitude pulmonary edema with absent right pulmonary artery. Pediatrics. 1985;75:314-317.
58. Hultgren H. High altitude pulmonary edema. In: Staub N, ed. Lung Water and Solute Exchange. New York, NY: Marcel Dekker; 1978:437-469.
59. Hlastala MP, Lamm WJ, Karp A, Polissar NL, Starr IR, Glenny RW. Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J Appl Physiol. 2004;96: 1589-1599.
60. Hanaoka M, Tanaka M, Ge RL, et al. Hypoxia-induced pulmonary blood redistribution in subjects with a history of high-altitude pulmonary edema. Circulation. 2000;101: 1418-1422.
61. Hopkins SR, Garg J, Bolar DS, Balouch J, Levin DL. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am J Respir Crit Care Med. 2005;171:83-87.
62. Dehnert C, Risse F, Ley S, et al. Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. Am J Respir Crit Care Med. 2006;174:1132-1138.
63. Planes C, Escoubet B, Blot-Chabaud M, Friedlander G, Farman N, Clerici C. Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells. Am J Respir Cell Mol Biol. 1997;17:508-518.
64. Vivona ML, Matthay M, Chabaud MB, Friedlander G, Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am J Respir Cell Mol Biol. 2001;25:554-561.
65. Mairbäurl H, Mayer K, Kim KJ, Borok Z, Bärtsch P, Crandall ED. Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol. 2002;282:L659-L665.
66. Mairbäurl H, Schwobel F, Hoschele S, et al. Altered ion transporter expression in bronchial epithelium in mountaineers with high-altitude pulmonary edema. J Appl Physiol. 2003;95:1843-1850.
67. Egli M, Duplain H, Lepori M, et al. Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. J Physiol. 2004;560(part 3):857-865.
68. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 2002;346:1631-1636.
69. Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345:107-114.
70. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. 2006;145:497-506.
71. Bartsch P, Vock P, Franciolli M. High altitude pulmonary edema after successful treatment of acute mountain sickness with dexamethasone. J Wilderness Med. 1990;1:162-164.
72. Murata T, Hori M, Sakamoto K, Karaki H, Ozaki H. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am J Respir Crit Care Med. 2004;170:647-655.
73. Asoh K, Kumai T, Murano K, Kobayashi S, Koitabashi Y. Effect of antenatal dexamethasone treatment on Ca2+-dependent nitric oxide synthase activity in rat lung. Pediatr Res. 2000;48:91-95.
74. Stelzner TJ, O'Brien RF, Sato K, Weil JV. Hypoxia-induced increases in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids. J Clin Invest. 1988; 82:1840-1847.
75. Noda M, Suzuki S, Tsubochi H, et al. Single dexamethasone injection increases alveolar fluid clearance in adult rats. Crit Care Med. 2003;31:1183-1189.
76. Guney S, Schuler A, Ott A, et al. Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1332-L1338.
77. Saldias FJ, Lecuona E, Cornelias AR Ridge KM, Rutschman DH, Sznajder JI. Beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. Am J Respir Crit Care Med. 2000;162:282-287.
78. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALT1): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006; 173:281-287.
79. Parker JC, Ivey CL. Isoproterenol attenuates high vascular pressure-induced permeability increases in isolated rat lungs. J Appl Physiol. 1997;83:1962-1967.
80. Adding L, Agvald P, Artlich A, Persson M, Gustafson L. Beta-adrenoceptor agonist stimulation of pulmonary nitric oxide production in the rabbit. Br J Pharmacol. 1999;126: 833-839.
81. Berg J, Ramanathan S, Swenson E. Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats. Wilderness Environ Med. 2004;15:32-37.
82. Teppema LJ, Balanos GM, Steinback CD, et al. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med. 2007;175:277-281.
83. Höhne C, Pickerodt PA, Francis RC, Boemke W, Swenson ER. Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol. 2007;292:L178-L184.
84. Höhne C, Krebs MO, Seiferheld M, Boemke W, Kaczmarczyk G, Swenson ER. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs. J Appl Physiol. 2004;97:515-521.
85. Deem S, Hedges RG, Kerr ME, Swenson ER. Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs. Respir Physiol. 2000;123:109-119.
86. Shimoda LA, Luke T, Sylvester JT, Shih HW, Jain A, Swenson ER. Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1002-L1012.
87. Hohenhaus E, Niroomand F, Goerre S, Vock P, Oelz O, Bartsch P. Nifedipine does not prevent acute mountain sickness. Am J Respir Crit Care Med. 1994;150:857-860.
88. Marticorena E, Hultgren HN. Evaluation of therapeutic methods in high altitude pulmonary edema. Am J Cardiol. 1979;43:307-312.
89. Zafren K, Reeves JT, Schoene R. Treatment of high-altitude pulmonary edema by bed rest and supplemental oxygen. Wilderness Environ Med. 1996;7:127-132.
90. Bärtsch P. Treatment of high altitude diseases without drugs. Int J Sports Med. 1992;13(suppl 1):S71-S74.
91. Freeman K, Shalit M, Stroh G. Use of the Gamow bag by EMT-Basic park rangers for treatment of high-altitude pulmonary edema and high-altitude cerebral edema. Wilderness Environ Med. 2004;15:198-201.
92. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary oedema. Lancet. 1989;2:1241-1244.
93. Oelz O, Noti C, Ritter M, Jenni R, Bärtsch P. Nifedipine for high altitude pulmonary oedema. Lancet. 1991;337: 556.
94. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med. 1996;334:624-629.
95. Anand IS, Prasad BA, Chugh SS, et al. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation. 1998;98:2441-2445.
96. Schoene RB, Roach RC, Hackett PH, Harrison G, Mills WJ Jr. High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley: effect of expiratory positive airway pressure. Chest. 1985;87:330-333.